Recruitment has opened for a controversial new clinical trial which would see humans implanted with brain slugs.
The news follows approval from the UNE’s Food & Drug Administration (FDA) earlier this year.
Trial patients will have a slug placed deep within their mid-brain via an orifice of their choosing, and will be monitored to test the safety and functionality of the slug-host symbiosis.
“We are extremely excited about this next chapter for humanity,” the brain slug collective stated in a press release issued today, adding “join us.”
The brain slugs have sought FDA approval four times, however previous bids were rejected due to safety concerns about side effects, including host death on attempted removal of implanted slugs.
The FDA states it was convinced to authorize the approval after its entire staff were offered a visit to an implantation center.
If clinical trials succeed, the brain slugs will require further regulatory approval prior to launching on the wider market. Xenonion understands that the slugs have already extended invites to the UNE’s Trade Commission and other government officials to tour their facility.